HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ines Martin-Padura Selected Research

Polycythemia (Erythrocytosis)

8/2010EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ines Martin-Padura Research Topics

Disease

7Neoplasms (Cancer)
07/2014 - 01/2009
2Breast Neoplasms (Breast Cancer)
10/2013 - 01/2012
2Atherosclerosis
09/2008 - 02/2003
2Vascular Diseases (Vascular Disease)
03/2007 - 02/2003
1Ductal Carcinoma
07/2014
1Noninfiltrating Intraductal Carcinoma (DCIS)
07/2014
1Residual Neoplasm
07/2012
1Hepatocellular Carcinoma (Hepatoma)
07/2012
1Liver Neoplasms (Liver Cancer)
07/2012
1Lymphoma (Lymphomas)
10/2011
1Polycythemia (Erythrocytosis)
08/2010
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2009
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2008
1Leukemia
11/2008
1Atherosclerotic Plaque (Atheroma)
09/2008
1Diabetic Angiopathies (Diabetic Angiopathy)
03/2007
1Diabetes Mellitus
03/2007
1Body Weight (Weight, Body)
03/2007
1Hyperglycemia
03/2007
1Inflammation (Inflammations)
03/2005
1Arthritis (Polyarthritis)
03/2005
1Contact Dermatitis (Eczema, Contact)
09/2004
1Ischemia
06/2004

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
07/2014 - 03/2007
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2007 - 06/2004
1GTP Phosphohydrolases (GTPases)IBA
07/2014
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
07/2014
1Phenobarbital (Luminal)FDA Link
10/2013
1LuciferasesIBA
07/2012
1ubenimexIBA
07/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2012
1erucylphosphocholineIBA
01/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2011
1Lenalidomide (CC 5013)FDA Link
10/2011
1Therapeutic UsesIBA
10/2011
1Sunitinib (Sutent)FDA Link
09/2011
1Amino AcidsFDA Link
08/2010
1NucleotidesIBA
08/2010
1Codon (Codons)IBA
08/2010
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
08/2010
1Glutamic Acid (Glutamate)FDA Link
08/2010
1Imatinib Mesylate (Gleevec)FDA Link
12/2009
1Biomarkers (Surrogate Marker)IBA
01/2009
1Apolipoproteins E (ApoE)IBA
09/2008
1ApolipoproteinsIBA
09/2008
1Streptozocin (Streptozotocin)FDA Link
03/2007
1IntegrinsIBA
03/2005
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
03/2005
1Junctional Adhesion Molecule AIBA
09/2004
1oxidized low density lipoproteinIBA
02/2003

Therapy/Procedure

4Therapeutics
07/2012 - 02/2003
1Metronomic Administration
07/2012
1Drug Therapy (Chemotherapy)
07/2012
1Mammaplasty (Breast Reconstruction)
01/2012
1Transplantation
11/2008
1Tourniquets
06/2004